title: A strategy for prophylactic vaccination against HIV.
authors.affiliation: Salk Institute for Biological Studies, San Diego, CA 92138.
authors.forename: J
authors.initials: J
authors.lastname: Salk
authors.forename: P A
authors.initials: PA
authors.lastname: Bretscher
authors.forename: P L
authors.initials: PL
authors.lastname: Salk
authors.forename: M
authors.initials: M
authors.lastname: Clerici
authors.forename: G M
authors.initials: GM
authors.lastname: Shearer
mesh_terms: D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000517:prevention & control*; D000276:Adjuvants, Immunologic; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D015483:HIV Antibodies / Q000096:biosynthesis; D015488:HIV Antigens / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D000882:Haplorhini; D006801:Humans; D007111:Immunity, Cellular; D007156:Immunologic Memory; D051379:Mice; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014611:Vaccination
chemical_list: D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D016207:Cytokines; D015483:HIV Antibodies; D015488:HIV Antigens